Grant: Idea to Innovation
University of Victoria
$20,000.00
L2M NSERC: 3D bioprinted artificial skin for testing dermatological products
EF 2023-24
Résumé
3D bioprinting enables to generation of human tissue models that can replicate the structures and functions found in vivo. Such bioprinted tissues can serve as a more relevant human system for testing the toxicity and efficacy potential drug targets in a more relevant fashion compared to using animal models. Animal models often fail to predict the toxicity of potential drug targets and Europe has banned the testing of cosmetics on animals. Drug and cosmetic formulations are often designed to interact with the skin, which the largest organ in human body. Thus, a huge market exists for human skin models that can serve as a test bed for such products. This project will build upon our team's expertise in using our novel bioinks to develop human tissue models and apply this expertise to generating complex skin constructs. This Lab to Market project will be conducted by Giselle Diez - an award winning biomedical engineer at the University of Victoria - whose thesis work is focused on 3D bioprinting skin tissues. This project will be conducted under the guidance of Dr. Willerth - an internationally recognized expert in 3D printing and tissue engineering.
Programme
Idea to Innovation
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
590722-2024
Name nom
Willerth, Stephanie SM
Department département
Mechanical Engineering
Organization id
7
Institution établissement
University of Victoria
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2024
Award amount
20000
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Biomedical engineering
Research subject en
Génie biomédical
Research subject fr
Génie biomédical
Application title
L2M NSERC: 3D bioprinted artificial skin for testing dermatological products
Keyword
3D printing; additive manufacturing; biomaterials; cell biology; cell culture; drug testing; fibroblasts; skin; toxicity
Application summary
3D bioprinting enables to generation of human tissue models that can replicate the structures and functions found in vivo. Such bioprinted tissues can serve as a more relevant human system for testing the toxicity and efficacy potential drug targets in a more relevant fashion compared to using animal models. Animal models often fail to predict the toxicity of potential drug targets and Europe has banned the testing of cosmetics on animals. Drug and cosmetic formulations are often designed to interact with the skin, which the largest organ in human body. Thus, a huge market exists for human skin models that can serve as a test bed for such products. This project will build upon our team's expertise in using our novel bioinks to develop human tissue models and apply this expertise to generating complex skin constructs. This Lab to Market project will be conducted by Giselle Diez - an award winning biomedical engineer at the University of Victoria - whose thesis work is focused on 3D bioprinting skin tissues. This project will be conducted under the guidance of Dr. Willerth - an internationally recognized expert in 3D printing and tissue engineering.